Post Partum Hemorrhage
2
Pipeline Programs
4
Companies
4
Clinical Trials
3 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
iNova PharmaceuticalsAustralia - Chatswood
2 programs1
Tranexamic acidPhase 2
Masimo Root Radical 7 Pulse CO-OximeterN/A1 trial
Active Trials
One BiosciencesFrance - Paris
1 programEstablishment of a simulation lab and provision of simulation based trainingsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Human BioSciencesTranexamic acid
iNova PharmaceuticalsMasimo Root Radical 7 Pulse CO-Oximeter
One BiosciencesEstablishment of a simulation lab and provision of simulation based trainings
Novo NordiskEptacog alfa
Clinical Trials (4)
Total enrollment: 3,692 patients across 4 trials
Prevention of Postpartum Hemorrhage With Tranexamic Acid
Start: Dec 2022Est. completion: Jun 2027120 patients
Phase 2Recruiting
Hemoglobin Testing in Pregnant Patients
Start: Dec 2025Est. completion: Dec 2026250 patients
N/ARecruiting
NCT06577922One BiosciencesEstablishment of a simulation lab and provision of simulation based trainings
Evaluation of Maternal & Newborn Health Simulation Lab Centers of Excellence in Nepal
Start: May 2024Est. completion: Jul 2026
N/ARecruiting
NovoSeven® in Severe Postpartum Haemorrhage - Experiences From UK, DK, FR, NL
Start: May 2020Est. completion: Jan 20213,322 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 actively recruiting trials targeting 3,692 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.